Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.
HTL Biotechnology 与 Terasaki Institute for Biomedical Innovation 宣布签署有关生物材料转化研究的谅解备忘录。
“Terasaki Institute 在开发可生物打印的、基于生物聚合物的技术方面处于世界领先地位，该技术有望彻底变革药物递送、可穿戴设备和植入式器械。我们希望与 HTL 合作，在精准医学和再生医学的关键领域推出基于生物聚合物的新一代应用。”Terasaki Institute for Biomedical Innovation 的首席创新官Maurizio Vecchione 补充道。
阅读下面的更多信息。
英语法语
